2013
DOI: 10.1016/j.critrevonc.2013.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Cancer in developing countries: The next most preventable pandemic. The global problem of cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
60
0
2

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(63 citation statements)
references
References 15 publications
0
60
0
2
Order By: Relevance
“…Cancer is a global problem that accounts for almost 13% of deaths worldwide, there will be between 15 and 17 million new cases of cancer every year, 60% of which will be in developing countries (Lopez-Gomez et al, 2013). Breast cancer is one of the most prevalent cancers in women worldwide, accounting for 23% of the total cancer cases.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer is a global problem that accounts for almost 13% of deaths worldwide, there will be between 15 and 17 million new cases of cancer every year, 60% of which will be in developing countries (Lopez-Gomez et al, 2013). Breast cancer is one of the most prevalent cancers in women worldwide, accounting for 23% of the total cancer cases.…”
Section: Introductionmentioning
confidence: 99%
“…In French Guiana, early detection and prevention programs are crucial for increasing cancer survival, notably for foreign-born patients. Late diagnosis, advanced stage at diagnosis, difficulties in accessing treatment facilities, and absence of prevention and screening are common problems in tropical countries which generally are of low and middle-low income [5][6][7][8][9]. Surprisingly this is also the case for a large proportion of the population in French Guiana [10].…”
Section: Discussionmentioning
confidence: 98%
“…Cervical cancer incidence and mortality rates are much lower in high-resource settings because of the implementation of organized screening programs based on Pap and/or HPV testing, diagnosis by colposcopy and biopsy, and timely treatment of cervical precancer and early-stage cancer. However, many lowincome and middle-income countries have been unable to implement such screening programs because of the high cost of the necessary infrastructure and the lack of qualified personnel (Wright and Kuhn, 2012;López-Gómez et al, 2013). Screening programs are also hampered by loss to follow-up of screen-positive women, who do not receive accurate diagnosis and timely treatment.…”
Section: Introductionmentioning
confidence: 97%